Pharmaceuticals · Quality Systems
Pharmaceutical Quality Systems Consulting
The short answer
A pharmaceutical quality system is the set of connected processes — documents, changes, deviations, CAPA, training, release, review — that keep product decisions defensible. We assess whether those connections actually work in your operation, then rebuild the ones that do not.
01
Why this matters
- Quality systems fail at the interfaces: a change that never triggered a revalidation assessment, a deviation that never fed CAPA, a CAPA that never reached training.
- Systems designed for a 40-person company are frequently still in use at 400 people, and the strain shows up as backlog.
- Management review without meaningful metrics produces governance in name only.
02
Applicable regulations and standards
- 21 CFR 211 Subpart B
- Organization and personnel, including quality control unit responsibilities.
- ICH Q10
- Pharmaceutical quality system elements and management responsibilities.
- ICH Q9(R1)
- Quality risk management, including risk-based decision-making and subjectivity controls.
- 21 CFR 211.180 / 211.192
- Records, product quality review and investigation of discrepancies.
03
What our consultants actually do
- Map the current quality system as it is actually operated and compare it to the documented system
- Redesign document control, change control and record architecture to reduce friction and duplication
- Rebuild deviation and CAPA processes with risk-based triage and real effectiveness verification
- Establish quality metrics, management review and escalation paths that surface issues early
- Define quality oversight of contract operations, including agreements and audit cadence
- Provide experienced interim quality leadership while the system is being rebuilt
04
Across the product lifecycle
01 / DEVELOP
Phase-appropriate quality system scaled to clinical activity.
02 / SCALE
System capacity expanded ahead of headcount and batch volume.
03 / TRANSFER
Quality oversight defined across sites and partners.
04 / VALIDATE
Validation status controlled through change management.
05 / MANUFACTURE
Deviation, CAPA and release operating within committed timelines.
06 / MAINTAIN
Internal audit, metrics and product quality review closing the loop.
05
Problems we are usually called about
- Deviation and CAPA backlog treated as a resourcing problem rather than a design problem
- Change control that assesses regulatory impact but not validation or training impact
- Product quality review compiled as a report nobody uses to make decisions
- Multiple document systems after an acquisition with no single source of truth
- Internal audits scheduled but findings never trended
06
Typical deliverables
- Quality system assessment against cGMP and ICH Q10 with risk ranking
- Target-state quality system design and procedure architecture
- Backlog reduction plan for deviations and CAPAs
- Quality metrics dashboard definition and management review agenda
- Effectiveness verification protocol for remediated elements
07
Frequently asked
- How long does a quality system remediation take?
- Scope decides. A focused rebuild of deviation and CAPA processes is typically months; a full multi-system remediation with effectiveness verification is usually a year or more of staged work with defined milestones.
- Can you work with our existing electronic quality management system?
- Yes. Most remediation involves configuring and using the existing system properly rather than replacing it. Where a configuration genuinely blocks compliant practice, we document the case for change.
- Do you provide interim quality leadership?
- We do, where the engagement is genuinely about building capability rather than permanently outsourcing the quality unit's judgment.
08
References
More for pharmaceuticals
cGMP, validation and manufacturing quality support for drug products.
- Process ValidationProcess validation for a drug product is a three-stage lifecycle: design the process and its control strategy, qualify commercial-scale performance, and then verify that the process stays in control for as long as it is used.
- Cleaning ValidationCleaning validation demonstrates that a documented cleaning procedure consistently reduces residues to scientifically justified limits on shared equipment.
- cGMP ConsultingcGMP consulting for a drug manufacturer means making 21 CFR Parts 210 and 211 operable in your facility — with procedures your staff can follow, records that reconstruct what happened and a quality unit with the authority to act.
- Technology TransferTechnology transfer succeeds or fails on what the receiving site is given: process understanding, not just a batch record.
- IND CMC SupportSponsors filing an IND usually need two things at once: CMC content for the application and a quality system capable of overseeing clinical manufacturing.
- NDA Manufacturing SupportThis is the site-side companion to an NDA filing: making sure the validated process, the control strategy and the records at the manufacturing site match what the application says, and that the people there can explain it during a pre-approval inspection..
Start a project
Tell us what you're working on.
Describe the product, the process or the problem. We will tell you honestly whether we are the right people to help, and who should be on the team if we are.